Share-based Payment Arrangement, Expense of Singular Genomics Systems, Inc. from 30 Jun 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Singular Genomics Systems, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2020 to 30 Sep 2024.
  • Singular Genomics Systems, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $2,165,000, a 23% decline year-over-year.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11,404,000, a 17% decline from 2022.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13,669,000, a 48% increase from 2021.
  • Singular Genomics Systems, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9,231,000, a 771% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Singular Genomics Systems, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,165,000 -$629,000 -23% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q1 2024 $11,219,000 $2,896,000 -$185,000 -6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $11,404,000 $2,687,000 -$412,000 -13% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2024 2023 FY
Q3 2023 $11,816,000 $2,794,000 -$605,000 -18% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $12,421,000 $2,842,000 -$763,000 -21% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $13,184,000 $3,081,000 -$485,000 -14% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $13,669,000 $3,099,000 +$164,000 +5.6% 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $13,505,000 $3,399,000 +$540,000 +19% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $12,965,000 $3,605,000 +$1,264,000 +54% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $11,701,000 $3,566,000 +$2,470,000 +225% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $9,231,000 $2,935,000 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $2,859,000 +$2,588,000 +955% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $2,341,000 +$2,081,000 +800% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $1,096,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q3 2020 $271,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $260,000 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2

Singular Genomics Systems, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $11,404,000 -$2,265,000 -17% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2024 2023 FY
2022 $13,669,000 +$4,438,000 +48% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
2021 $9,231,000 +$8,171,000 +771% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $1,060,000 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.